A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas

Cancer Research

Volumn 68, Issue 24, 2008, Pages 10324-10332

  Tuomisto, Anne ^a   Sund, Malin ^a   Tahkola, Jenni ^a   Latvanlehto, Anne ^a   Savolainen, Eeva Riitta ^a   Autio Harmainen, Helena ^a   Liakka, Annikki ^a   Sormunen, Raija ^a   Vuoristo, Jussi ^a   West, Anne ^b   Lahesmaa, Riitta ^b   Morse III, Herbert C ^c   Pihlajaniemi, Taina ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 13;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; IMMUNE RESPONSE; MACROPHAGE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; BASEMENT MEMBRANE; COLLAGEN TYPE XIII; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, MUCOSAL; INTESTINE, SMALL; LYMPHOMA, B-CELL; MICE; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 57749094103     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2582     Document Type: Article

References (42)

1. Kuppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001;20:5580-94.
2. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer 2005;5:251-62.
3. Potter M. Neoplastic development in plasma cells. Immunol Rev 2003;194:177-95.
4. Qi CF, Hori M, Coleman AE, et al. Genomic organisation and expression of BCL6 in murine B-cell lymphomas. Leuk Res 2000;24:719-32.
5. Janz S, Potter M, Rabkin CS. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer 2003; 36:211-23.
6. Messmer BT, Albesiano E, Efremov DG, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004;200:519-25.
7. Hussell T, Isaacson PG, Crabtree JE, Spencer J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996;178: 122-7.
8. Monti S, Savage KJ, Kutok JL, et al. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005;105:1851-61.
9. Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004;351: 2159-69.
10. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004;4:11-22.
11. Nykvist P, Tu H, Ivaska J, Kapyla J, Pihlajaniemi T, Heino J. Distinct recognition of collagen subtypes by α(1)β(1) and α(2)β(1) integrins. α(1)β(1) mediates cell adhesion to type XIII collagen. J Biol Chem 2000;275: 8255-61.
12. Lebbink RJ, de Ruiter T, Adelmeijer J, et al. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 2006;203:1419-25.
13. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45.
14. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
15. Hägg P, Rehn M, Huhtala P, Väisänen T, Tamminen M, Pihlajaniemi T. Type XIII collagen is identified as a plasma membrane protein. J Biol Chem 1998;273:15590-7.
16. Hägg P, Väisänen T, Tuomisto A, et al. Type XIII collagen: a novel cell adhesion component present in a range of cell-matrix adhesions and in the intercalated discs between cardiac muscle cells. Matrix Biol 2001;19: 727-42.
17. Sund M, Ylönen R, Tuomisto A, et al. Abnormal adherence junctions in the heart and reduced angiogenesis in transgenic mice overexpressing mutant type XIII collagen. EMBO J 2001;20:5153-64.
18. Tahkola J, Räsänen J, Sund M, Mäikallio K, Autio-Harmainen H, Pihlajaniemi T. Cardiac dysfunction in transgenic mouse fetuses overexpressing shortened type XIII collagen. Cell Tissue Res 2008;333:61-9.
19. Nicklas W, Baneux P, Boot R, et al. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim 2002;36: 20-42.
20. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001;98: 31-6.
21. Hartley JW, Chattopadhyay SK, Lander MR, et al. Accelerated appearance of multiple B cell lymphoma types in NFS/N mice congenic for ecotropic murine leukemia viruses. Lab Invest 2000;80:159-69.
22. Morse HC III, Qi CF, Chattopadhyay SK, et al. Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice. Leuk Res 2001;25:719-33.
23. Ward JM. Lymphomas and leukemias in mice. Exp Toxicol Pathol 2006;57:377-81.
24. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization series on classification of tumors: pathology and genetics of tumors of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
25. Morse HC III, Anver MR, Fredrickson TN, et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 2002;100:246-58.
26. Qi CF, Zhou JX, Lee CH, et al. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. Cancer Res 2007;67:2439-47.
27. Byrd LG, McDonald AH, Gold LG, Potter M. Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane. J Immunol 1991;147: 3632-7.
28. Potter M, Wax JS, Anderson AO, Nordan RP. Inhibition of plasmacytoma development in BALB/c mice by indomethacin. J Exp Med 1985;161:996-1012.
29. Enzler T, Gillessen S, Manis JP, et al. Deficiencies of GM-CSF and interferon g link inflammation and cancer. J Exp Med 2003;197:1213-9.
30. Zangani MM, Froyland M, Qiu GY, et al. Lymphomas can develop from B cells chronically helped by idiotype-specific T cells. J Exp Med 2007;204:1181-91.
31. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006;107:3034-44.
32. Lecuit M, Abachin E, Martin A, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004;350:239-48.
33. Kvist AP, Latvanlehto A, SundM, et al. Lack of cytosolic and transmembrane domains of type XIII collagen results in progressive myopathy. Am J Pathol 2001;159:1581-92.
34. Tu H, Sasaki T, Snellman A, et al. The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin. J Biol Chem 2002;277:23092-9.
35. Meyaard L, Adema GJ, Chang C, et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 1997;7:283-90.
36. van der Vuurst de Vries AR, Clevers H, Logtenberg T, Meyaard L. Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is differentially expressed during human B cell differentiation and inhibits B cell receptor-mediated signaling. Eur J Immunol 1999;29:3160-7.
37. Poggi A, Tomasello E, Ferrero E, Zocchi MR, Moretta L. p40/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony-stimulating factor. Eur J Immunol 1998;28:2086-91.
38. Maasho K, Masilamani M, Valas R, Basu S, Coligan JE, Borrego F. The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation. Mol Immunol 2005;42:1521-30.
39. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000;290:84-9.
40. Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc(γ)RIIB-deficient mice results from strain-specific epistasis. Immunity 2000;13:277-85.
41. Pritchard NR, Smith KG. B cell inhibitory receptors and autoimmunity. Immunology 2003;108:263-73.
42. Mizokami T, Salvi M, Wall JR. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon? J Endocrinol Invest 2004;27: 221-9.